NEW YORK, Dec. 30, 2017 -- The global microbial identification market is expected to witness a CAGR of 5.6%, and is projected to reach USD 1,562.6 million by 2023. The growth in the microbial identification market is attributed to the rising cases of infectious diseases across the globe, technological advancements in microbial identification, and growing concerns related to the safety and quality of food. The report segments microbial identification market by Product (Instruments, Consumables, Services), Method (Phenotypic, Genotypic), Application (Diagnostic Applications, Food And Beverage Testing, Pharmaceutical Applications, Environmental Applications, Others), End-User (Hospitals and Blood Banks, Food and Beverage Manufacturing Companies, Pharmaceutical Companies and Research Laboratories, Environmental Research Agencies, Others), and Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa (MEA)). The report studies the global microbial identification market over the forecast period (2017-2023).
Browse full research report with TOC on "Global Microbial Identification Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023" at: https://www.energiasmarketresearch.com/global-microbial-identification-market-outlook/
Microbial Identification is a crucial activity to identify a contaminating organism for its removal and destruction. Microorganisms such as bacteria and fungi can contaminate raw materials, production facilities, and branded products. Microbial identification is used in a wide variety of applications including pharmaceutical, food, energy, environment, and health sector.
Key findings from the report:
- The global microbial identification market is expected to reach USD 1,562.6 million by 2023
- The consumables product segment holds the major share of the global microbial identification market in 2016, and is expected to hold its dominance during 2017-2023
- The phenotypic identification method segment held the major market in 2016. However, the genotypic identification method segment is expected to show higher CAGR during the forecast period
- North America holds the largest share of the global microbial identification market and is projected to continue its dominance over the forecast period
- The Asia-Pacific region is expected to witness highest CAGR during 2017-2023
- Some of the key companies operating in the microbial identification market include Thermo Fisher Scientific Inc., Biomérieux S.A., Wickham Laboratories Ltd, Inc., Danaher Corporation, Biolog Inc., Bruker Corporation, Becton, Dickinson and Company, Qiagen N.V., Midi Inc., Charles River Laboratories Inc., among others
Genotypic identification segment to witness higher growth rate than traditional Phenotypic techniques.
There are a variety of techniques to identify a given microbial specimen. The traditional methods includes phenotypic techniques which use gram staining, culture and biochemical methods. However, these methods of identification can be used only for organisms that can be cultivated in vitro. Moreover these methods are complex and time consuming. Modern method of genotypic identification has emerged as an alternative or complement to phenotypic methods. These methods use molecular techniques by doing DNA or RNA analysis of the microbial genomes. Genotypic microbial identification methods are more reliable,accurate, definitive and provides rapid detection and identification of microbes.
Microbial Identification Market - Regional insight
North America holds the largest share of the global microbial identification market and is projected to continue its dominance over the forecast period. The factors driving the growth includes increasing number of research and development activities coupled with technological advancements in microbial identification in the region. Asia-Pacific is projected to acheive high growth rate during the forecast period in the global microbial identification market, owing to increased healthcare spending and high prevalence of infectious diseases in the region.
About Energias Market Research Pvt. Ltd. –
Energias Market Research launched with the objective to provide in-depth market analysis, business research solutions, and consultation that is tailored to our client’s specific needs based on our impeccable research methodology.
With a wide range of expertise from various industrial sectors and more than 50 industries that include energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.
Our comprehensive industry-specific knowledge enables us in creating high quality global research outputs. This wide-range capability differentiates us from our competitors.
Contact:
Manas Nagi
Business Development Manager
For any queries email us: [email protected]
Call us: +1-716-239-4915
Visit: https://www.energiasmarketresearch.com/


Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 



